Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss

NCT02379650 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Testing required by FDA for IND approval was too expensive to move forward with conduct of the study.

Conditions

Interventions

Sponsor

University of Utah

Collaborators